By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Chemin Messidor 5-7
Case Postale 5911
Lausanne    CH - 1002  Switzerland
Phone: 41-21-321-0111 Fax: 41-21-321-0169


Company News
Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy 9/8/2015 6:56:36 AM
Debiopharm Acquires FibroTrap Sample Processing Technology From Spinomix 6/16/2015 9:32:39 AM
Debiopharm Announces Phase III Positive Results For Triptorelin 6-Month Formulation In The Management Of Central Precocious Puberty (CPP) 5/19/2015 6:22:16 AM
Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1450 In Staphylococcal Skin Infections 4/23/2015 9:01:14 AM
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015 11:07:17 AM
Debiopharm Regains Full Rights To Alisporivir Program 1/12/2015 7:16:22 AM
FDA Grants Fast Track Designation To Debiopharm's Antibiotic Debio 1450 1/8/2015 7:57:38 AM
Presented By The Japanese Cancer Association And Debiopharm Group™, The 'JCA-Mauvernay Award 2014' Goes To Doctors Hara And Shibata 9/29/2014 8:37:57 AM
Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species 6/26/2014 10:06:15 AM
Debiopharm And TCG Lifesciences Announce Successful Completion Of First Phase Of Research Collaboration On Discovery Of Novel Antibiotics 6/24/2014 9:18:59 AM